Barcelona, Spain
The Drug Discovery Innovation Programme (DDIP) is a fantastic opportunity to connect with industry leaders and gain insights from top experts in drug discovery. We’re looking forward to attending this event in Barcelona and contributing to the discussions that will shape the future of the pharmaceutical industry.
More importantly, we are eager to discuss your upcoming projects in greater detail and explore how we can collaborate to advance cell therapy.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.
Let's chat about it at DDIP 2024.